New research reveals chronic exposure to air pollution significantly raises the risk of blood clots, particularly from fine particulate matter and nitrogen dioxide. Linked to strokes and venous ...

If you have diabetes, taking a GLP-1 medicine could lower your odds for a common form of blood clot Venous thromboembolisms (VTEs) include deep vein thrombosis, clots that can form in the legs A new ...

SAN DIEGO — More in-patients with AKI quickly received care based on best practices when a kidney action team sent recommendations to health care providers via electronic health records ...

A meta-analysis of the four relevant randomized clinical trials evaluating direct oral anticoagulants (DOACs) versus warfarin in thrombotic antiphospholipid syndrome (APS) showed a significant ...

The risk-benefit profile of upadacitinib for rheumatoid arthritis “remains favorable” through 5 years, according to data published in The Journal of Rheumatology.In a long-term extension of ...

Background: Since the onset of widespread COVID-19 vaccination campaigns, there have been concerns about serious cardiovascular adverse events, including myocarditis, myocardial infarction, and venous ...

Objective: This study set out to determine risk factors for hospital-acquired venous thromboembolisms (VTEs) in pediatric cardiology patients in the setting of the 2016 Solutions for Patient Safety ...

How common are venous thromboembolisms (VTEs) in patients presenting with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and what is the effect on prognosis, hospital length of ...

The risk for venous thromboembolisms was lower among patients with atopic dermatitis vs those with ankylosing spondylitis, Crohn disease, inflammatory bowel disease, psoriasis, psoriatic arthritis, ...

Patients recently treated for cancer who required hospitalization for COVID-19 were at risk for venous thromboembolisms (VTEs), recent research has found, with investigators determining that patients ...

Researchers from the University of Texas Medical Branch have found that adding statin therapy may help lower venous thromboembolism risk in women taking menopausal hormone therapy.